71335-2227 Dexamethasone - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

71335-2227

Brand Name:

Dexamethasone

Generic Name:

Dexamethasone

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: DEXAMETHASONE

Strength: 4.0

Unit: mg/1

Packages:

Code: 71335-2227-00

Description: 4 TABLET in 1 BOTTLE (71335-2227-0)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-01

Description: 30 TABLET in 1 BOTTLE (71335-2227-1)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-02

Description: 6 TABLET in 1 BOTTLE (71335-2227-2)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-03

Description: 3 TABLET in 1 BOTTLE (71335-2227-3)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-04

Description: 15 TABLET in 1 BOTTLE (71335-2227-4)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-05

Description: 40 TABLET in 1 BOTTLE (71335-2227-5)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-06

Description: 60 TABLET in 1 BOTTLE (71335-2227-6)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-07

Description: 28 TABLET in 1 BOTTLE (71335-2227-7)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-08

Description: 90 TABLET in 1 BOTTLE (71335-2227-8)

Effective Date: Aug. 28, 2023

Discontinued:

Code: 71335-2227-09

Description: 10 TABLET in 1 BOTTLE (71335-2227-9)

Effective Date: Aug. 28, 2023

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Adrenal Glucocorticoid

Minor Class:

Corticosteroid

Orphan Drug Designation:

Status:

In Use